title: [Myeloid growth factors. New indications with many questions].
authors.affiliation: Forskare vid MFR och högskolelektor, Södersjukhuset, Stockholm.
authors.forename: J
authors.initials: J
authors.lastname: Palmblad
authors.forename: J
authors.initials: J
authors.lastname: Samuelsson
authors.forename: B
authors.initials: B
authors.lastname: Glimelius
authors.forename: P
authors.initials: P
authors.lastname: Ljungman
authors.forename: P G
authors.initials: PG
authors.lastname: Nilsson
mesh_terms: D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000191:economics / Q000627:therapeutic use*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000191:economics / Q000627:therapeutic use*; D006133:Growth Substances; D006801:Humans; D000078224:Lenograstim; D011994:Recombinant Proteins / Q000191:economics / Q000627:therapeutic use
chemical_list: D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D006133:Growth Substances; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000078224:Lenograstim; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; C082430:molgramostim; D000069585:Filgrastim